Chronic sinusitis in head and neck cancer patients who received radiotherapy or chemoradiotherapy

Young Min Park, Jae-Gu Cho, Jeong-Soo Woo

Research output: Contribution to journalArticle

Abstract

Purpose: The aim of this study was to evaluate the status of paranasal sinus and to identify risk factors associated with the development of chronic sinusitis based on imaging studies in head and neck cancer patients. Materials and methods: We retrospectively analyzed the medical records of 186 patients who were diagnosed with head and neck squamous cell carcinoma at Korea University Guro Hospital from February 2003 to July 2015. Only patients with at least 1 year of follow-up after treatment were included. Results: Chronic sinusitis occurred in 32 patients (17.2%), including seven patients (16.3%) in non-radiotherapy group and 25 patients (17.5%) in radiotherapy group. Maxillary sinus was most commonly involved (56.9%), followed by ethmoid, frontal, and sphenoid sinuses. Age (1.006; 0.874–1.158; p = 0.936), TNM stage (0.104; 0.007–1.598; p = 0.105), and underlying disease (0.242; 0.036–1.646; p = 0.147) were not significantly associated with the need for surgery due to sinusitis. Although radiotherapy itself (1.319; 0.019–2.821; p = 0.251) was not significantly associated with surgery due to sinusitis, concurrent chemotherapy (10.729; 1.361–84.611; p = 0.024) was significantly associated with surgical procedures. Conclusion: Higher T stage and concurrent chemotherapy with radiotherapy showed significant association with chronic sinusitis. Concurrent chemotherapy also showed significant association with surgical treatment in head and neck cancer patients. Therefore, more careful surveillance and aggressive treatment of chronic sinusitis is needed in head and neck cancer patients who receive radiotherapy with concurrent chemotherapy or higher T stage.

Original languageEnglish
JournalEuropean Archives of Oto-Rhino-Laryngology
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Sinusitis
Chemoradiotherapy
Head and Neck Neoplasms
Radiotherapy
Drug Therapy
Ethmoid Sinus
Sphenoid Sinus
Frontal Sinus
Maxillary Sinus
Paranasal Sinuses
Korea
Medical Records
Therapeutics

Keywords

  • Chemotherapy
  • Chronic sinusitis
  • Head and neck cancer
  • Radiotherapy

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

@article{fb43cdf90e5042afae44dd49c4dcfcbc,
title = "Chronic sinusitis in head and neck cancer patients who received radiotherapy or chemoradiotherapy",
abstract = "Purpose: The aim of this study was to evaluate the status of paranasal sinus and to identify risk factors associated with the development of chronic sinusitis based on imaging studies in head and neck cancer patients. Materials and methods: We retrospectively analyzed the medical records of 186 patients who were diagnosed with head and neck squamous cell carcinoma at Korea University Guro Hospital from February 2003 to July 2015. Only patients with at least 1 year of follow-up after treatment were included. Results: Chronic sinusitis occurred in 32 patients (17.2{\%}), including seven patients (16.3{\%}) in non-radiotherapy group and 25 patients (17.5{\%}) in radiotherapy group. Maxillary sinus was most commonly involved (56.9{\%}), followed by ethmoid, frontal, and sphenoid sinuses. Age (1.006; 0.874–1.158; p = 0.936), TNM stage (0.104; 0.007–1.598; p = 0.105), and underlying disease (0.242; 0.036–1.646; p = 0.147) were not significantly associated with the need for surgery due to sinusitis. Although radiotherapy itself (1.319; 0.019–2.821; p = 0.251) was not significantly associated with surgery due to sinusitis, concurrent chemotherapy (10.729; 1.361–84.611; p = 0.024) was significantly associated with surgical procedures. Conclusion: Higher T stage and concurrent chemotherapy with radiotherapy showed significant association with chronic sinusitis. Concurrent chemotherapy also showed significant association with surgical treatment in head and neck cancer patients. Therefore, more careful surveillance and aggressive treatment of chronic sinusitis is needed in head and neck cancer patients who receive radiotherapy with concurrent chemotherapy or higher T stage.",
keywords = "Chemotherapy, Chronic sinusitis, Head and neck cancer, Radiotherapy",
author = "Park, {Young Min} and Jae-Gu Cho and Jeong-Soo Woo",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/s00405-018-5114-1",
language = "English",
journal = "European Archives of Oto-Rhino-Laryngology",
issn = "0937-4477",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Chronic sinusitis in head and neck cancer patients who received radiotherapy or chemoradiotherapy

AU - Park, Young Min

AU - Cho, Jae-Gu

AU - Woo, Jeong-Soo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: The aim of this study was to evaluate the status of paranasal sinus and to identify risk factors associated with the development of chronic sinusitis based on imaging studies in head and neck cancer patients. Materials and methods: We retrospectively analyzed the medical records of 186 patients who were diagnosed with head and neck squamous cell carcinoma at Korea University Guro Hospital from February 2003 to July 2015. Only patients with at least 1 year of follow-up after treatment were included. Results: Chronic sinusitis occurred in 32 patients (17.2%), including seven patients (16.3%) in non-radiotherapy group and 25 patients (17.5%) in radiotherapy group. Maxillary sinus was most commonly involved (56.9%), followed by ethmoid, frontal, and sphenoid sinuses. Age (1.006; 0.874–1.158; p = 0.936), TNM stage (0.104; 0.007–1.598; p = 0.105), and underlying disease (0.242; 0.036–1.646; p = 0.147) were not significantly associated with the need for surgery due to sinusitis. Although radiotherapy itself (1.319; 0.019–2.821; p = 0.251) was not significantly associated with surgery due to sinusitis, concurrent chemotherapy (10.729; 1.361–84.611; p = 0.024) was significantly associated with surgical procedures. Conclusion: Higher T stage and concurrent chemotherapy with radiotherapy showed significant association with chronic sinusitis. Concurrent chemotherapy also showed significant association with surgical treatment in head and neck cancer patients. Therefore, more careful surveillance and aggressive treatment of chronic sinusitis is needed in head and neck cancer patients who receive radiotherapy with concurrent chemotherapy or higher T stage.

AB - Purpose: The aim of this study was to evaluate the status of paranasal sinus and to identify risk factors associated with the development of chronic sinusitis based on imaging studies in head and neck cancer patients. Materials and methods: We retrospectively analyzed the medical records of 186 patients who were diagnosed with head and neck squamous cell carcinoma at Korea University Guro Hospital from February 2003 to July 2015. Only patients with at least 1 year of follow-up after treatment were included. Results: Chronic sinusitis occurred in 32 patients (17.2%), including seven patients (16.3%) in non-radiotherapy group and 25 patients (17.5%) in radiotherapy group. Maxillary sinus was most commonly involved (56.9%), followed by ethmoid, frontal, and sphenoid sinuses. Age (1.006; 0.874–1.158; p = 0.936), TNM stage (0.104; 0.007–1.598; p = 0.105), and underlying disease (0.242; 0.036–1.646; p = 0.147) were not significantly associated with the need for surgery due to sinusitis. Although radiotherapy itself (1.319; 0.019–2.821; p = 0.251) was not significantly associated with surgery due to sinusitis, concurrent chemotherapy (10.729; 1.361–84.611; p = 0.024) was significantly associated with surgical procedures. Conclusion: Higher T stage and concurrent chemotherapy with radiotherapy showed significant association with chronic sinusitis. Concurrent chemotherapy also showed significant association with surgical treatment in head and neck cancer patients. Therefore, more careful surveillance and aggressive treatment of chronic sinusitis is needed in head and neck cancer patients who receive radiotherapy with concurrent chemotherapy or higher T stage.

KW - Chemotherapy

KW - Chronic sinusitis

KW - Head and neck cancer

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85053256283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053256283&partnerID=8YFLogxK

U2 - 10.1007/s00405-018-5114-1

DO - 10.1007/s00405-018-5114-1

M3 - Article

C2 - 30167838

AN - SCOPUS:85053256283

JO - European Archives of Oto-Rhino-Laryngology

JF - European Archives of Oto-Rhino-Laryngology

SN - 0937-4477

ER -